<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" title="XSL_formatting" href="http://www.mstrust.org.uk/news/rss/rss.xsl"?><rss version="2.0"><channel><title><![CDATA[MS Trust Stop Press]]></title><link><![CDATA[http://2008.mstrust.org.uk]]></link><description><![CDATA[]]></description><language><![CDATA[en-us]]></language><lastBuildDate><![CDATA[Thu, 18 Mar 2010 00:01:02 +0000]]></lastBuildDate><copyright><![CDATA[Multiple Sclerosis Trust, Spirella Building, Letchworth Garden City, Herts SG6 4ET]]></copyright><docs><![CDATA[http://blogs.law.harvard.edu/tech/rss]]></docs><generator><![CDATA[www.idnet.net]]></generator><ttl><![CDATA[60]]></ttl><item><title><![CDATA[MS Trust welcomes efforts to improve UK's clinical research system ]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3581]]></link><description><![CDATA[The MS Trust welcomes news of the preliminary success of a partnership project between the Department of Health, the NHS, and the pharmaceutical industry aimed at improving the allure of the UK as a centre for international drug development.


]]></description><pubDate><![CDATA[Wed, 17 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3581]]></guid></item><item><title><![CDATA[MS Trust news survey - tell us what you want]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3578]]></link><description><![CDATA[Where do you find news about MS?  What type of news are you looking for?  How can we improve the presentation of news on the website? These are some of the questions featured in the MS Trust news survey.

]]></description><pubDate><![CDATA[Tue, 16 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3578]]></guid></item><item><title><![CDATA[MS Trust to benefit form Fontwell Park Lunch]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3579]]></link><description><![CDATA[Fontwell Park Racecourse has chosen to support the MS Trust and Kim Underwood with a charity lunch on the 12th May, to be held in the luxurious parade ring marquee. ]]></description><pubDate><![CDATA[Tue, 16 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3579]]></guid></item><item><title><![CDATA[Study into impact of advanced MS on the family unit published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3577]]></link><description><![CDATA[An MS Trust funded  study exploring family relationships and support needs when adapting to a relative's advanced MS has been published in the journal Psychology and Health.

]]></description><pubDate><![CDATA[Mon, 15 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3577]]></guid></item><item><title><![CDATA[Meeting addresses vital role of MS nurses]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3574]]></link><description><![CDATA[The MS nurses specialists annual meeting that took place recently in York stressed the importance of the role for people with multiple sclerosis.]]></description><pubDate><![CDATA[Fri, 12 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3574]]></guid></item><item><title><![CDATA[Vitamin D boost for the immune system]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3572]]></link><description><![CDATA[Several newspapers this week reported on newly published research that indicated a key role for vitamin D in boosting the immune system by triggering and arming the body's T cells, the cells in the body that seek out and destroy any invading bacteria and viruses.


]]></description><pubDate><![CDATA[Thu, 11 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3572]]></guid></item><item><title><![CDATA[Unproven procedure halted after serious adverse events]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3550]]></link><description><![CDATA[The latest issue of the journal <em>Annals of Neurology</em> reports on two serious incidents which led to the suspension of further procedures to treat CCSVI at Stanford Medical Center.

]]></description><pubDate><![CDATA[Tue, 2 Mar 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3550]]></guid></item><item><title><![CDATA[New assisted suicide guidelines published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3547]]></link><description><![CDATA[The Director of Public Prosecutions (DPP) has issued new guidelines on whether someone will be prosecuted for helping someone to die.
]]></description><pubDate><![CDATA[Fri, 26 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3547]]></guid></item><item><title><![CDATA[MS Trust supports RCN's call for more investment in specialist nurses]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3543]]></link><description><![CDATA[The MS Trust supports the call by the Royal College of Nursing (RCN) for greater investment in specialist nurses to support people with long-term conditions such as multiple sclerosis (MS).


]]></description><pubDate><![CDATA[Wed, 24 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3543]]></guid></item><item><title><![CDATA[Teen soap tackles MS]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3541]]></link><description><![CDATA[Teen soap Hollyoaks, which was aired recently on Channel 4 has introduced a storyline depicting one of its characters living with MS. ]]></description><pubDate><![CDATA[Tue, 23 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3541]]></guid></item><item><title><![CDATA[Fingolimod granted priority review in the States]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3537]]></link><description><![CDATA[Fingolimod (brand name Gilenia) is a new oral treatment for relapsing remitting MS.  Applications for licensing were submtted to the regulators in the US and Europe in December 2009.  The Food and Drug Administration (FDA) in the US has granted priority review to fingolimod.





]]></description><pubDate><![CDATA[Mon, 22 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3537]]></guid></item><item><title><![CDATA[MS Trust comments on Radio 5 Risk-sharing Scheme programme]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3538]]></link><description><![CDATA[The Donal MacIntyre show on Radio 5 covered the Department of Health Risk-sharing Scheme last night.


]]></description><pubDate><![CDATA[Mon, 22 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3538]]></guid></item><item><title><![CDATA[Vitamin D - the latest information]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3530]]></link><description><![CDATA[With much data being published recently about the influence of sunlight and vitamin D on the incidence of MS the MS Trust has produced a new factsheet summarising the latest information.




]]></description><pubDate><![CDATA[Thu, 18 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3530]]></guid></item><item><title><![CDATA[MS Trust comments on new data on CCSVI]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3520]]></link><description><![CDATA[Preliminary results from a study of CCSVI report an association with people with MS.
]]></description><pubDate><![CDATA[Fri, 12 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3520]]></guid></item><item><title><![CDATA[Making information about medicines available online]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3502]]></link><description><![CDATA[The MHRA (Medicines and Healthcare products Regulatory Agency), the UK medicines' regulator, is seeking views on making information on medicines available to the public.
]]></description><pubDate><![CDATA[Tue, 9 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3502]]></guid></item><item><title><![CDATA[MP calls for abolition of the MS drugs risk-sharing scheme]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3499]]></link><description><![CDATA[The Risk-sharing Scheme, the mechanism that makes disease modifying drugs for MS available on the NHS, was debated in Parliament on 2 February.
]]></description><pubDate><![CDATA[Mon, 8 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3499]]></guid></item><item><title><![CDATA[Oral drugs for MS]]></title><link><![CDATA[http://www.mstrust.org.uk/atoz/oral_drugs.jsp]]></link><description><![CDATA[With the new oral drugs continuing to be a focus of interest, the MS Trust has put together information on the research into cladribine and fingolimod.]]></description><pubDate><![CDATA[Tue, 2 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/atoz/oral_drugs.jsp]]></guid></item><item><title><![CDATA[Exciting new exercise resource launched for people with MS ]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3479]]></link><description><![CDATA[Following the success of the book <em>Exercises for people with MS</em>,  the MS Trust has launched a new set of web pages full of exercises for people with MS. 
]]></description><pubDate><![CDATA[Mon, 1 Feb 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3479]]></guid></item><item><title><![CDATA[More oral MS drug research results published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3472]]></link><description><![CDATA[Research published in the New England Journal of Medicine (NEJM) suggests that the oral drug cladribine reduces relapse rates and disease progression in people with relapsing remitting MS.
]]></description><pubDate><![CDATA[Tue, 26 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3472]]></guid></item><item><title><![CDATA[Update - fampridine approved by US drugs regulator]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3464]]></link><description><![CDATA[The US Food and Drug Administration (FDA) has approved fampridine - brand name Ampyra - as a treatment to improve walking ability in people with multiple sclerosis.  
]]></description><pubDate><![CDATA[Mon, 25 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3464]]></guid></item><item><title><![CDATA[Tysabri labelling changes recommended]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3463]]></link><description><![CDATA[The European Medicines Agency has recommended new measures for dealing with the risks associated with the drug natalizumab (Tysabri).
]]></description><pubDate><![CDATA[Fri, 22 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3463]]></guid></item><item><title><![CDATA[Oral MS drug research results published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3452]]></link><description><![CDATA[Research published online today in the New England Journal of Medicine (NEJM) suggests the new oral drug fingolimod may be more effective than current disease modifying drugs for MS.

]]></description><pubDate><![CDATA[Thu, 21 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3452]]></guid></item><item><title><![CDATA[Has MS affected your work?]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3454]]></link><description><![CDATA[The Multiple Sclerosis International Federation (MSIF) is carrying out a global survey to find out more about how having MS impacts on employment.
]]></description><pubDate><![CDATA[Wed, 20 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3454]]></guid></item><item><title><![CDATA[Fampridine submitted to licensing body]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3443]]></link><description><![CDATA[Fampridine, a new oral drug to improve walking ability in some people with multiple sclerosis, has been submitted for a licence to the EMEA, the European regulator.
]]></description><pubDate><![CDATA[Wed, 13 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3443]]></guid></item><item><title><![CDATA[MS Trust remains cautious about CCSVI]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3441]]></link><description><![CDATA[With CCSVI again in the news, the MS Trust suggests caution in considering surgery based on what is still a theory being investigated by researchers.]]></description><pubDate><![CDATA[Tue, 12 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3441]]></guid></item><item><title><![CDATA[MS Circuit Challenge at Goodwood Motor Circuit]]></title><link><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/goodwood/default.jsp]]></link><description><![CDATA[A fun packed day is on offer with a cycle race around the motor circuit in the morning, followed by a family event in the afternoon where you can complete the circuit "by any means"!]]></description><pubDate><![CDATA[Mon, 11 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/fundraising/events/ukevents/goodwood/default.jsp]]></guid></item><item><title><![CDATA[American researchers to explore stem cell repair procedure]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3434]]></link><description><![CDATA[Researchers in the USA are recruiting for a trial that will look at the safety and tolerability of a procedure that attempts to treat MS damage in the central nervous system with an individual's own stem cells.]]></description><pubDate><![CDATA[Fri, 8 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3434]]></guid></item><item><title><![CDATA[Medications organiser iPhone app launched]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3427]]></link><description><![CDATA[A iPhone application to help people manage their injections has been developed by a man with multiple sclerosis.]]></description><pubDate><![CDATA[Tue, 5 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3427]]></guid></item><item><title><![CDATA[MS more prevalent in people born in spring]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3423]]></link><description><![CDATA[Newly published research from Scotland suggests that babies born in spring face an increased risk of developing multiple sclerosis later in life.]]></description><pubDate><![CDATA[Mon, 4 Jan 2010 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3423]]></guid></item><item><title><![CDATA[The MS Trust welcomes review of research into cannabis ]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3413]]></link><description><![CDATA[A systematic review of randomized controlled trials has reported that cannabis can reduce spasticity in people with multiple sclerosis (MS).]]></description><pubDate><![CDATA[Wed, 23 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3413]]></guid></item><item><title><![CDATA[Revised ABN guidelines published]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3414]]></link><description><![CDATA[At long last the new Association of British Neurologists (ABN) revised (2009) guidelines for prescribing disease modifying drugs in multiple sclerosis have been published.]]></description><pubDate><![CDATA[Wed, 23 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3414]]></guid></item><item><title><![CDATA[Keep in touch with the MS Trust]]></title><link><![CDATA[http://www.mstrust.org.uk/about/keep_in_touch.jsp]]></link><description><![CDATA[Trying to keep up to date with MS can sometimes seem overwhelming. To help you get straight to the information you want, there are a number of ways you can have news about MS and the work of the MS Trust sent to you directly.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/about/keep_in_touch.jsp]]></guid></item><item><title><![CDATA[MS Trust suggests caution about CCSVI]]></title><link><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3411]]></link><description><![CDATA[CCSVI (chronic cerebro-spinal venous insufficiency), the theory that an abnormal narrowing in blood vessels that take blood from the brain might be a cause of MS symptoms or perhaps MS itself, remains a widely discussed topic in the media.]]></description><pubDate><![CDATA[Tue, 22 Dec 2009 00:00:00 +0000]]></pubDate><guid><![CDATA[http://www.mstrust.org.uk/news/article.jsp?id=3411]]></guid></item></channel></rss>
